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Abstract
X-linked disorders with cerebellar dysgenesis (XLCD) are a genetically heterogeneous and clinically variable group
of disorders in which the hallmark is a cerebellar defect (hypoplasia, atrophy or dysplasia) visible on brain imaging,
caused by gene mutations or genomic imbalances on the X-chromosome. The neurological features of XLCD
include hypotonia, developmental delay, intellectual disability, ataxia and/or other cerebellar signs. Normal
cognitive development has also been reported. Cerebellar dysgenesis may be isolated or associated with other
brain malformations or multiorgan involvement. There are at least 15 genes on the X-chromosome that have been
constantly or occasionally associated with a pathological cerebellar phenotype. 8 XLCD loci have been mapped
and several families with X-linked inheritance have been reported. Recently, two recurrent duplication syndromes
in Xq28 have been associated with cerebellar hypoplasia. Given the report of several forms of XLCD and the excess
of males with ataxia, this group of conditions is probably underestimated and families of patients with
neuroradiological and clinical evidence of a cerebellar disorder should be counseled for high risk of X-linked
inheritance.
Disease names and synonyms
X-linked Congenital Ataxias
X-Linked Disorders/Syndromes with Cerebellar
Dysgenesis
Definition and classification
The term X-linked disorders with cerebellar dysgenesis
(XLCD) is used here to describe an emerging group of
rare conditions in which the hallmark is a cerebellar
defect, visible on neuroimaging, caused by gene muta-
tions or genomic imbalances on the X-chromosome. A
classification of this group of rare disorders is still diffi-
cult because in most cases the pathogenesis is unknown.
The best characterized forms are X-linked syndromes
with associated cerebellar hypoplasia due to OPHN1 or
CASK gene mutations. In other X-linked disorders like
Fragile X, Oral-facial-digital type I or Opitz GBBB syn-
dromes, cerebellar defects are increasingly being
recognized.
Epidemiology
The overall incidence of congenital cerebellar malforma-
tions is high, 1/4,000-5,000 live births, the contribution
of X-linked forms is probably underestimated.
Clinical and molecular description
a. X-linked non-progressive congenital ataxias
Congenital ataxias (CA) were first defined by Batten in
1905 [1] as “cases in which ataxia has been noted early
in life and in which there is a tendency to gradual
improvement”. This heterogeneous group of disorders
accounts for 10% of non-progressive infantile encepha-
lopathies [2]. The first X-linked form was described in
a large family of Eastern Russian descent with seven
affected males over three generations. All patients had
markedly delayed early developmental milestones, cere-
bellar ataxia, external ophthalmoplegia, pyramidal
signs, normal cognitive development and a non-pro-
gressive course. Neuroimaging studies revealed marked
hypoplasia/atrophy of the cerebellar vermis and hemi-
spheres. Linkage studies mapped the gene to a large
genetic interval on Xp11.21-Xq24 with a maximum lod
score of 4.66 at DXS1059 [3]. A second family was
reported with a similar phenotype, the propositus and
his maternal uncle manifesting severe hypotonia at
birth, psychomotor delay, slow eye movements, non
progressive ataxia and normal intelligence [4]. Neuroi-
maging studies revealed global cerebellar hypoplasia/
atrophy not evident in the first years of life. Despite
the cerebellar changes, the clinical course was non-
progressive, as it is expected in this group of ataxias. A
g e n e t i ci n t e r v a l ,p a r t i a l l yo v e r l a p p i n gw i t ht h ef i r s t
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A large family of Norwegian descent with six affected
males over three generations with non-progressive X-
linked congenital ataxia and normal cognitive develop-
ment was reported [5]. Hypotonia and overall delay of
motor development were noted since birth. Nystagmus,
dysarthria and trunkal ataxia were present. Neuroima-
ging studies showed global hypoplasia/atrophy of the
cerebellum, predominant in the vermis (Figure 1a-c)
The condition was mapped to a genetic interval of 12
Mb at Xq25-q27.1 with a maximum lod score of 3.44
at DXS1192 not overlapping with the previously identi-
fied locus, indicating that there are at least two genes
responsible for this rare forms of X-linked congenital
ataxia.
b. X-linked genes/syndromes with cerebellar dysgenesis
Oligophrenin-1 syndrome
The OPHN1 syndrome (MIM 300486) was first described
in a 12 year-old girl, carrier of a de novo translocation t
(X;12)(q11;q15) which was found to disrupt the Oligo-
phrenin-1 (OPHN1) gene at Xq12 and encodes a RhoGT-
Pase activating protein (RhoGAP) involved in synaptic
morphogenesis and function [6-8]. The girl had congeni-
tal hypotonia, severe developmental delay, moderate cog-
nitive impairment, early-onset complex partial seizures
and bilateral divergent strabismus and dysmetria. At a
later reevaluation, Brain MRI showed a posterior vermis
dysgenesis including partial agenesis of lobules VI and
VII associated with right vermian parasagittal cleft and
mild cerebellar hemisphere hypoplasia. A consistent
Figure 1 Brain MRI studies of patients with XLCD. 1 a-c (male proband of a family with X-linked congenital ataxia) Midsagittal T1-weighted
image showing an overall size reduction of the cerebellum predominant in the vermis with widened interfolia sulci. Brainstem is normal (a).
Axial T2-weighted image showing global cerebellar hypoplasia without dysplasia (b). Axial T2-weighted image showing normal cortex and
ventricles (c). d-f (male patient carrying a OPHN1 mutation): midsagittal T1-weighted image showing hypoplastic cerebellar vermis and enlarged
cisterna magna (d) axial T2-weighted image showing cerebellar hypoplasia and vermis dysplasia (e) axial T2-weighted image showing lateral
ventricle dilatation and mild cortical atrophy (f). g-i (female patient carrying a CASK mutation): Midsagittal T1-weighted image showing moderate
vermis hypoplasia and flat pons (g). Axial T2-weighted image showing simplified gyral pattern and ventricular dilatation (h). Coronal T2-weighted
image showing global cerebellar hypoplasia and simplified cortical gyri (i).
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cal atrophy was also present. A similar clinico-radiologi-
cal phenotype (Figure 1a-c) was found in the affected
males of a family carrying a single nucleotide deletion in
exon 19 of the OPHN1, initially diagnosed with non-syn-
dromic X-linked mental retardation [9]. Another deletion
comprising exon 19 of the OPHN1 gene, was identified
in a family with five affected males showing moderate to
severe mental retardation, infantile-onset epilepsy, hypo-
tonia, strabismus and ataxia. Cryptorchidism and genital
hypoplasia were present in all affected males. Neurora-
diological findings included cortical atrophy, enlargement
of the cerebral ventricles, bilateral hypoplasia of the head
of the caudate nucleus, lower vermis and cerebellar hemi-
sphere hypoplasia. One carrier sister had mild learning
disabilities and strabismus but her brain MRI was normal
[10]. A stop mutation in exon 3 and an 8 base-pair inser-
tion in exon 9 of the OPHN1 gene were identified in two
other families with a similar phenoype [11]. In a family
with a 2 base-pair deletion in exon 8 of OPHN1 leading
to a premature stop codon, the affected males showed
developmental and cognitive delay with IQ ranging from
46 to 54, strabismus, early-onset generalized tonic-clonic
seizures, abnormal behaviour and a characteristic facial
phenotype with long face, prominent forehead, infraorbi-
tal creases, deep set eyes, upturned philtrum and large
ears. The obligate carrier females showed only mild cog-
nitive impairment and subtle facial changes. Brain MRI
studies performed in the propositus at age 3 months
showed underdeveloped frontal lobes, loss of brain
volume with enlarged lateral ventricles, prominent subar-
achnoid spaces and a particular square shape of the fron-
tal horns. Cerebellar hypoplasia and vermis dysgenesis
with a large cisterna magna and a retrocerebellar cyst
were noted [12].
A de novo translocation disrupting the OPHN1 gene in a
female patient and intragenic deletions of OPHN1 detected
by arrayCGH, in a male patient and in two families in
which affected individuals all showed the characteristic
clinico-radiological phenotype associated with OPHN1
syndrome were also reported [13-16]. In one family with
six affected males with intellectual deficit, minor facial
anomalies, cubitus valgus, with or without sensorineural
deafness, a deletion of exons 16-18 in the OPHN1 gene
was identified [17]. Screening OPHN1 in a large cohort of
patients led to the identification of mutations in 12% of
individuals with intellectual deficit and cerebellar hypopla-
sia, suggesting that the screening of this gene should be
implemented in boys with vermis hypoplasia, enlarged cer-
ebral ventricles and developmental delay [18].
CASK syndrome
CASK syndrome (MIM 300749) was first described in a 4
year-old girl, carrier of an apparently de novo paracentric
inversion 46X, inv(X)(p11.4p22.3) disrupting the
Calcium/Calmodulin dependent serine protein kinase
(CASK) gene, located at Xp11.4, which encodes a multi-
domain scaffolding protein that belongs to the mem-
brane-associated guanylate kinase protein family of
proteins found at neuronal synapses involved in the traf-
ficking, targeting and signalling of ion channels [19,21].
The patient showed marked congenital and postnatal
microcephaly, severe developmental delay, seizures and
sensorineural hearing loss. She had minor facial anoma-
lies: low forehead, hypertelorism, broad nasal bridge,
smooth philtrum, large ears, micrognathia. She also had
episodic hyperpnea and optic disc pallor with anisocoria.
Brain MRI showed cerebellar hypoplasia predominant in
the vermis, a small pons with flattened basis pontis,
mildly enlarged 4th ventricle and reduced number and
complexity of cortical gyri (Figure 1g-i). By screening a
series of patients with microcephaly, developmental delay
and pontine and cerebellar hypoplasia, two heterozygous
deletions identified by arrayCGH and one missense
mutation in exon 21 leading to a premature stop codon,
were found in three girls with a clinical and neuroradio-
logical phenotype very similar to the first described
patient. A hemizygous mutation partially affecting the
splice of exon 9 in a severely affected boy who died at
two weeks was also found [20]. Mid-hindbrain hypoplasia
was more severe, the corpus callosum was thin and
unmyelinated and the cortex showed area of pachygyria.
Neuropathologic examination of the cerebellum showed:
poorly formed and unbranched folia, a virtually absent
internal granular layer and an abnormally thick external
granular layer. The molecular layer was hypercellular and
disorganized. A missense mutation of CASK which par-
tially disrupts the splicing of exon 2, was identified in a
family with three affected males diagnosed with FG syn-
drome (MIM 305450) and congenital hypotonia, chronic
constipation, severe mental retardation, bilateral sensori-
neural deafness, seizures and hyperactive, aggressive
behaviour. The mother of the propositus showed mild
intellectual impairment and experienced absence attacks.
In addition, all mutant males had relative macrocephaly
and minor facial anomalies: broad forehead, frontal
upsweep of the hair, hypertelorism, saddle-root of nose,
long philtrum, and micrognathia. Brain MRI of the pro-
positus was normal [22]. Three novel missense mutations
and one splice site mutation of CASK were found in 4
families with mild to moderate X-linked mental retarda-
tion and congenital nystagmus. Affected individuals had
normal head circumference or relative macrocephaly.
Brain imaging was only performed in 2 of the 4 families:
in the propositus of one family MRI showed pachygyria
and cerebellar hypoplasia, while in the other family with
half of the affected individuals having normal cognitive
development, MRI was reported normal. Ocular findings
included: strabismus, cataracts, myopia or reduced visual
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but not all affected individuals. In 2 additional families
with apparently non-syndromic XLMR, novel missense
mutations in exon 8 and 27 of the CASK gene were iden-
tified [23]. Thus the phenotypes associated with CASK
mutations range from mild MR with or without congeni-
tal nystagmus, to severe cognitive impairment associated
with cerebellar and pontine hypoplasia and abormalities
of cortical development.
Christianson syndrome
Christianson syndrome (MIM 300243) was first described
in a South African family of Norwegian descent in which
16 affected males manifested profound MR, absence
speech, early-onset generalized tonic-clonic epilepsy, bilat-
eral ophthalmoplegia and truncal/gait ataxia. Three of the
10 obligate carrier females had mental retardation. In the
patients, developmental milestones were severely retarded
and hypotonia was present. The chest was narrow, limb
muscles were poorly developed, and joints were stiff and
contractured. MRI scan showed a prominent cisterna
magna, enlarged 4th ventricle, cerebellopontine and supra-
cerebellar cisterna, hypoplasia/atrophy of the cerebellum
predominantly of the vermis and pons. Most of the
affected males in this family died prematurely, around age
25-30 years. Neuropathological examination showed an
atrophic cerebellum, especially of the vermis. The molecu-
lar layer displayed microcystic changes and there was
widespread neuronal loss in the granular and PC layers, in
the pons and in the hippocampi. The condition was
mapped by linkage analysis studies to Xq24-q27 [24]. In
this family, a 2 base-pair deletion within the coding
sequence of the Solute Carrier family 9 member 6
(SLC9A6) was identified [25]. SLC9A6 is located at Xq26.3
and encodes a sodium/hydrogen exchanger protein 6
(NHE6) which regulates the endoluminal pH of early
endosomes involved in the trafficking of proteins essential
for growth and maintainance of dendritic spines [26].
Additional mutations of SLC9A6: a 6 base-pair deletion, a
nonsense mutation R468X, a splice site mutation causing
skipping of exon 3, were identified in three other families
with an Angelman-like phenotype characterized by devel-
opmental delay, postnatal microcephaly and epilepsy
occurring between 9 and 26 months of age. Patients exhib-
ited ataxia, hyperkinetic movements and frequent smiling
with episodes of unprovoked laughter, open mouth, pro-
fuse drooling and swallowing difficulties, gastroesophageal
reflux and thin body habitus.M R Is t u d i e sp e r f o r m e d3
years later in one affected child showed a mild progression
of the cerebellar atrophy. Proton Magnetic Resonance
spectroscopy (MRS) showed elevated glutamate/glutamine
in the basal ganglia of affected individuals. An additional
family of 6 affected males with severe mental retardation,
absent speech, autism spectrum disorder, epilepsy, late-
onset ataxia, weakness and dystonia with stereotyped hand
movements was reported and an in-frame 9 base-pair
deletion in SLC9A6 was identified. Brain MRI showed
moderate ventricular enlargement and sulcal widening due
to atrophy of the brain, thin corpus callosum but normal
cerebellum and brainstem. Post-mortem examination of
two affected males showed widespread neuronal loss and
deposits of the microtubule-binding protein tau in cortical
and sub-cortical regions which are generally the defining
neuropathological characteristics of a number of adult-
onset neurodegenerative disorders but had never been
seen before in early- onset cognitive delay or autism [27].
Fragile × syndrome
The Fragile × (FRAXA) syndrome (MIM 300624), is the
most frequent cause of monogenic mental retardation
with an estimated prevalence of 1/4000 males and 1/
8000 females. In addition to cognitive deficits, the phe-
notype of the syndrome include mild facial anomalies
(prominent jaw, high forehead, large ears), and macro-
orchidism. Many patients also manifest attention deficit
hyperactivity disorder and autistic-like behavior. The
syndrome is caused by a massive (more than 200) CGG
triplet expansion in the 5’ untranslated region of the
FMR1 gene which results in transcriptional silencing of
the gene [28]. Loss of function of the FMRP protein
leads to abnormalities of dendritic spine maturation
associated with altered synaptic plasticity and cerebellar
motor learning (eyeblink conditioning) also seen in
FRAXA patients [29]. A comparative study of the pos-
terior fossa of a group of mutated patients and a group
of age-matched controls revealed a significant reduction
of the posterior vermis (lobules VI-VII) in the Fragile ×
population [30,31]. These data were recently confirmed
by MRI morphometric studies in 3D [32].
Fragile X-associated Tremor/Ataxia syndrome
Fragile X-associated Tremor/Ataxia syndrome (FXTAS)
is characterized by adult-onset progressive intention tre-
mor and gait ataxia affecting more than 33% of male
and 10% of female carriers of expanded CGG triplets
alleles in the premutation range (50-200 repeats) of the
FMR1 gene and is uncoupled from FRAXA. Associated
features include cognitive decline, peripheral neuropa-
thy, dysautonomia [33]. The severity of both clinical and
neuropathological phenotypes (intranuclear inclusions,
especially abundant in the cerebellum) is correlated with
the extent of the CGG expansion, which in contrast to
FRAXA, leads to a marked increase of FMR1 transcrip-
tion. The consequence may be an RNA based “toxicity”
affecting the development and long-term function of
neural cells. Until recently FXTAS was defined as a late-
onset neurodegenerative disorder, but evidence from
animal models and from observations of children with
elevated levels of FMR1 mRNA showing developmental
delay, behaviour difficulties and increased seizure activ-
ity, suggest that the underlying pathogenic process may
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affected individuals show global loss of brain volume, in
particular cerebellar and cortical atrophy and hyperin-
tensity white matter lesions around the periventricular
area and in the middle cerebellar peduncles [35].
Hoyeraal-Hreidarsson syndrome
Hoyeraal-Hreidarsson syndrome (HHS) (MIM 300240)
is a rare X-linked recessive disorder, characterized by
intrauterine growth retardation, microcephaly, intellec-
tual deficit, bone marrow failure, cancer predisposition
and cerebellar hypoplasia [36]. It is caused by mutations
of DCK1 gene located on Xq28, encoding the nucleolar
protein dyskerin which interacts with the human telo-
merase RNA complex [37]. Detailed neuroimaging stu-
dies of an HHS patient showed global cerebellar
hypoplasia, a small brainstem, thin corpus callosum and
cerebral calcifications [38].
X-linked sideroblastic anemia with ataxia
X-linked sideroblastic anemia with ataxia (XLSA/A)
(MIM 301310) is a rare X-linked disorder characterised
by early onset slowly progressive ataxia associated with
as i d e r o b l a s t i ca n e m i ad u et omitochondrial iron accu-
mulation. It is caused by mutation of the ABC7 gene
which maps to Xq13 and encodes an ATP-binding
mitochondrial iron transporter located in the inner
mitochondrial membrane, involved in mitochondrial
iron homeostasis as well as in the maturation of cytoso-
lic iron-sulfur proteins [39]. Neuroimaging studies
showed global cerebellar hypoplasia with signs of atro-
phy in affected individuals [40].
Oral-Facial-Digital type I/X-linked Joubert syndrome
Oral-Facial-Digital type I (OFDI) (MIM 311200) is a
rare male lethal X-linked dominant syndrome charac-
terised by malformations of the mouth, face and digits
in affected females. CNS anomalies have been found in
40% of ODFI patients, in particular vermis hypoplasia,
corpus callosum agenesis, hydrocephalus and periventri-
cular heterotopia [41]. OFD1 maps to Xp22 and encodes
a ciliary protein. OFD1 mutations have been identified
in two families with retinitis pigmentosa, postaxial poly-
dactyly and the molar tooth sign characteristic of Jou-
bert and Joubert-related syndromes [42,43].
X-linked Opitz/GBBB syndrome
Opitz GBBB syndromes (MIM 300000) are X-linked reces-
sive or autosomal dominant conditions characterised by
developmental delay and midline malformations: hyperte-
lorism, cleft lip/palate oesophagolaryngotracheal defects,
imperforate anus and hypospadias [44,45]. The X-linked
form is caused by mutations in the MID1 gene which
maps to Xp22.22 and encodes a microtubule-associated
protein involved in ribonucleoprotein complex stabiliza-
tion and ubiquitination [46,47]. Anterior vermis hypoplasia
and corpus callosum abnormalities were found in more
than one third of patients with MID1 mutations [48,49]
and lack of mid1 in the mouse causes abnormal develop-
ment of the anterior cerebellar vermis [50].
X-linked heterotaxy
X-linked heterotaxy (MIM 306955) is caused by muta-
tions of the Zinc finger transcription factor ZIC3 located
in Xq26 and encodes a transcription factor involved in
the establishment of the left/right axis in early embryo-
nic development [51]. Vermis hypoplasia is found in X-
linked heterotaxy and has been reported in males hemi-
zygous for ZIC3 mutations [52,53]. Cerebellar dysgenesis
predominant in the flocculo-nodular lobe was described
in zic3 deficient mice [54].
X-linked cortical dysgenesis
The gene DCX located in Xq22 and encodes the Dou-
blecortin protein, mutated in 40% of type I lissence-
phaly. This cortical dysgenesis is associated with severe
mental retardation and seizures in affected males and
subcortical laminal heterotopia in heterozygous females
[55,56]. Doublecortin is a microtubule associated protein
which participates in the assembly and stabilization of
microtubules in migrating neuronal cells. 25% of male
patients with DCX mutations have mild cerebellar hypo-
plasia, predominant in the vermis [57,58].
The ARX gene located in Xp21, encodes an Aristaless-
related homeobox transcription factor involved in multi-
ple aspects of cortical development [59,60]. In a severe
case of X-linked lissencephaly, absent corpus callosum
and ambiguous genitalia (XLAG) due to a mutation in
ARX, neuroimaging studies showed a hypoplastic vermis
and enlarged 4th ventricle [61].
The gene FLNA maps to Xq28 and encodes Filamin 1,
a protein interacting with F-actin, involved in brain neu-
rogenesis and neuronal migration [62]. FLNA mutations
cause several different syndromes with a predominant
skeletal phenotype: Oto-palato digital type I and II, Mel-
nick Needles dysplasia, frontometaphyseal dysplasia, FG-
like syndrome [63]. Mutations of FLNA have also been
found in a high proportion of individuals with bilateral
periventricular nodular heterotopia, megacisterna
magna, cardiovascular malformations and epilepsy.
Almost all patients with FLNA mutations had mild to
moderate cerebellar hypoplasia [64].
Rett syndrome
Rett syndrome (MIM312750) is an X-linked dominant
neurodevelopmental disorder which represents the most
important cause of severe mental retardation in the
female population (1/10,000). Most cases are due to
mutations of the MECP2 gene in Xq28 which encodes a
Methyl-CpG DNA binding protein functioning as tran-
scriptional repressor [65]. This protein is highly
expressed in the CNS, in particular in the cortex, hippo-
campus and cerebellum. Initial psychomotor develop-
ment of Rett patients is apparently normal, then
regresses around 6-18 months with the appearance of
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seizures, epilepsy, loss of speech, hypotonia, ataxia and
hyperreflexia. MRI studies of young Rett patients have
demonstrated the presence of a mild cerebellar hypopla-
sia especially of lobules I-IV, whereas in adult patients a
progressive cerebellar atrophy was detected and also
confirmed by post-mortem neuropathologic studies of
the cerebellum [66,67]. Mecp2 mouse mutants show cer-
ebellar and hyppocampal-based learning deficits and
develop gait incoordination [68].
Xq28 microduplication syndromes
Duplications of the MECP2 region (MIM300260), cause
a syndrome of infantile hypotonia, profound intellectual
deficit, autistic features and recurrent infections [69].
Neuroradiological evidence of progressive cerebellar
atrophy, emerging in the second decade of life was
recently reported in males of three families carrying
duplications of the MECP2 region [70].
In 4 families with X-linked intellectual disabilities and a
copy number gain of an identical 0.3 Mb region in chro-
mosome band Xq28 including 19 annotated genes includ-
ing FLNA and GDI1 (an X-linked mental retardation
gene) but not MECP2, affected patients presented with
hypotonia, severely delayed psychomotor development,
mild ataxic gait, strabismus or nystagmus but no other
cerebellar signs. MRI of the brain showed mildly enlarged
fourth ventricle and ventricular dilatation in two unrelated
patients and a classical Dandy Walker malformation with
cerebellar hypoplasia and agenesis of the corpus callosum
in two other affected males. Minor facial anomalies were
present in all patients [71]. A fifth family with 3 affected
males carrying an identical Xq28 duplication and showing
mild to moderate intellectual disability associated with ver-
mis hypoplasia was reported [72].
X-linked hydrocephalus
X-linked hydrocephalus with aqueductal stenosis (MIM
30700) is the most common form of hereditary hydroce-
phalus with an incidence of 1/30,000 in male neonates.
Most cases of X-linked hydrocephalus, are caused by
mutations in the L1CAM gene, which encodes a cellular
adhesion protein implicated in the regulation of vesicle
cycling through its interaction with proteins of clathrin-
mediated endocytosis [73]. In patients with loss of func-
tion mutations of L1CAM, global vermis hypoplasia or
anterior vermis hypoplasia has been observed [74].
In a few families with X-linked mental retardation and
hydrocephalus mutations of AP1S2 (sigma subunit of
the clathrin adaptor protein complex 1) were identified.
Brain MRI imaging of affected males in one family
showed ventricular dilatation without aqueductal steno-
sis, calcifications of the basal ganglia, and mild vermis
hypoplasia [75,76]. Loss of function of the clathrin adap-
tor AP1 determines defects in synaptic vesicle cycling
with accumulation of large endosome-like vacuoles,
defects which are paired with reduced motor coordina-
tion and long term spatial memory in mutant mice [77].
A list of genes implicated in X-linked cerebellar dys-
genesis is provided in Table 1.
Table 1 List of genes implicated in X-linked cerebellar dysgenesis.
SYNDROME GENE CEREBELLAR PHENOTYPE CHROMOSOMAL
LOCALIZATION
MIM#
Oligophrenin-1 OPHN1 cerebellar hypoplasia (vermis lobules VI-VII) Xq12 300486
CASK CASK cerebellar hypoplasia Xp11.4 300749
Christianson SLC9A6 cerebellar atrophy Xq26 300231
Hoyeraal-Hreidarsson DCK1 global cerebellar hypoplasia Xq28 300240
X-linked sideroblastic anemia/Ataxia ABC7 global cerebellar atrophy Xq13 300240
Oral-facial-digital type I/X-linked
Joubert
OFD1 vermis hypoplasia/molar tooth sign Xp22 311200
Opitz GBBB MID1 anterior vermis hypoplasia Xp22 300000
FragileX/FXTAS FMR1 posterior vermis hypoplasia/cerebellar atrophy Xq27 300624/
300623
Rett MECP2 cerebellar atrophy Xq28 312750
MECP2/Xq28 duplications - Cerebellar atrophy/vermis hypoplasia (DWM
spectrum)
Xq28 300260/
300815
X-linked heterotaxy ZIC3 vermis hypoplasia Xq26 306955
X-linked hydrocephalus L1CAM global or anterior vermis hypoplasia Xq28 307000
Fried AP1S2 mild vermis hypoplasia Xp22 300630
X-linked lissencephaly with abnormal
genitalia
ARX severe cerebellar hypoplasia Xp21 300004
X-linked Lissencephaly DCX mild cerebellar hypoplasia (vermis) Xq22 300067
Oto-palato-digital type II FLNA mild cerebellar hypoplasia Xq28 300049
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- A four generation family of Dutch descent with nine
affected males presenting with severe cognitive delay,
early hypotonia with progression to spasticity and con-
tractures, choreoatetosis, seizures and a long narrow
face with coarse features was reported [78]. Brain ima-
ging studies revealed a cystic enlargement of the 4th
ventricle with cerebellar hypoplasia and iron accumula-
tion in the basal ganglia with neuroaxonal dystrophy.
The disease was mapped to the long arm of the X-chro-
mosome with a maximum lod score of 2.19 at DXS425
in Xq25-q27 [79].
- A family of Italian descent has been reported with 7
affected males, two of them showing severe congenital
ataxia, generalized hypotonia, psychomotor delay, recur-
rent bronchopulmonary infections later developing myo-
clonic encephalopathy and macular degeneration [80].
Serial neuroimaging studies showed cerebellar vermis
and corpus callosum hypoplasia, a cyst of the septum
pellucidum and persistence of the cavum vergae. The
other five affected males in the family had recurrent
bronchopneumonia with severe congenital hypotonia
and died within the first years of life. Immunologic
investigations only showed a reduced level of IgG2 sub-
class in one sib. The condition was mapped to the short
arm of the X-chromosome with a maximum lod score
of 2.48 at DXS7099 in Xp22.33-pter [81].
- A family with a syndromic form of X-linked mental
retardation characterized by absent speech, truncal
ataxia, contractures and hypoplasia of the cerebellum
and the brainstem revealed at neuroimaging studies was
reported. Only one of the affected males developed sei-
zures and showed changes in the basal ganglia suggest-
ing iron deposits. The condition was mapped to Xq23-
q24 [82].
- A family in which affected males showed congenital
cerebellar hypoplasia, microcephaly, short stature, pro-
found developmental delay, blindness, deafness and sei-
zures was described. Death occurred in infancy or early
childhood. This syndrome was mapped to Xq24-Xq27 [83].
- A family with 7 affected males presenting moderate
to severe intellectual impairment and infantile spams
was reported. Neuroimaging studies showed cerebellar
atrophy or corpus callosum hypoplasia or both, in half
of the affected individuals. The condition was mapped
to Xp11.4-p22.11 [84].
- A family with 3 males in two generations affected
with moderate intellectual deficit and prominent gla-
bella, synophris, prognathism, generalized hirsutism and
bilateral single palmar creases was described. All
patients developed seizures in childhood and two of
them showed a progressive gait disturbance and pro-
longed nerve conduction velocity and hypogammaglobu-
linemia. Neuroimaging studies in one patient revealed
cerebellar atrophy. The disorder was mapped to
Xq21.33-Xq23 [85].
Note: The clinical features of other XLCD for which
no mapping data are available [86-93] have been
reviewed by [5].
Diagnosis
Family history is important to exclude autosomal or
other forms of inheritance. In sporadic males or docu-
mented X-linked familiar cases, genetic testing, with the
possible exception of FMR1, should be performed only
in well selected patients with a specific clinical and neu-
roradiological phenotype as described in each paragraph
of the present review. A precise nosological classification
and a correlation between the neuroradiological pheno-
types (cerebellar hypoplasia, atrophy or dysplasia, brain-
stem and cerebellar hypoplasia, molar tooth sign) and
the genotype is still lacking but will certainly improve as
the genetic causes of these conditions are being identi-
fied and also thanks to the advancement of neuroima-
ging techniques (eg. tractography, voxel-based
morphometry). On the X-chromosome, a high incidence
of causal deletions and microduplications (pathogenic
copy number variations) was found, demonstrating that
dysregulated expression of tightly regulated genes can
disturb normal brain and cognitive development [94]. At
least 1/3 of cases with OPHN1 or CASK syndrome were
found to be carriers of a chromosomal or subchromoso-
mal abnormality. It is therefore recommended, in
patient with a neuroradiologically documented cerebellar
disorder, especially when two or more dysmorphic fea-
tures are present, to perform standard karyotype fol-
lowed by array-CGH studies.
Genetic counseling and prenatal diagnosis
Given the report of several forms of X-linked cerebellar
disorders and the excess of males with ataxia [95,96],
families of children with congenital cerebellar hypopla-
sia, atrophy or Dandy-Walker malformation with or
without intellectual disability, should be counseled for
high risk of X-linked inheritance. The identification of
the molecular defect in couples at risk, allows early pre-
natal testing whereas foetal brain neuroimaging may
prove uninformative.
Management, differential diagnosis and follow-up
Optimal management of these patients requires a multi-
disciplinary approach with particular attention to three-
generation family history and personal prenatal and
post-natal history to exclude infectious, toxic or trau-
matic etiology. A complete physical examination focused
on the presence of minor anomalies, an assessment of
multiorgan involvement and the search for associated
problems: neurosensorial deficits, seizures, specific
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conditions are syndromic. A cognitive and behavioural
assessment (Wechsler scales, Vineland) is essential
because X-linked cerebellar disorders are frequently
associated with mild to severe developmental/cognitive
delay. A Metabolic work-up (lactate/pyruvate ratio in
blood and spinal fluid, lysosomal enzymes, isoelectrofo-
cusing of transferrin, creatin kinase, very long chain
fatty acids, plasma and urinary aminoacids and urinary
organic acids chromatography) together with nerve con-
duction studies should be performed to exclude meta-
bolic or neuromuscular causes (pyruvate dehydrogenase
deficiency, X-linked adrenoleukodystrophy, X-linked
dystrophinopathies). Neuroimaging studies of the cere-
bellum with particular attention to the brainstem and
cerebral cortex, can be fundamental for the differential
diagnosis between different X-linked cerebellar syn-
dromes and other non cerebellar X-linked disorders that
can present with ataxic symptoms (e.g Arts syndrome,
characterized by ataxia, deafness and neuropathy). A
clinical and neuroradiological follow-up is also necessary
for the assessment of the natural history of the condi-
tion. Rehabilitation strategies should be planned for
motor, cognitive and behavioral difficulties and specific
manifestations such as visual impairment and seizures.
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